International Stem Cell Corporation
ISCO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,369 | $2,447 | $2,129 | $2,446 |
| % Growth | -3.2% | 14.9% | -13% | – |
| Cost of Goods Sold | $1,048 | $927 | $992 | $990 |
| Gross Profit | $1,321 | $1,520 | $1,137 | $1,456 |
| % Margin | 55.8% | 62.1% | 53.4% | 59.5% |
| R&D Expenses | $158 | $162 | $187 | $210 |
| G&A Expenses | $789 | $905 | $892 | $907 |
| SG&A Expenses | $1,069 | $1,191 | $1,165 | $1,195 |
| Sales & Mktg Exp. | $280 | $286 | $273 | $288 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,227 | $1,353 | $1,352 | $1,405 |
| Operating Income | $94 | $167 | -$215 | $51 |
| % Margin | 4% | 6.8% | -10.1% | 2.1% |
| Other Income/Exp. Net | -$37 | -$38 | -$41 | -$40 |
| Pre-Tax Income | $57 | $129 | -$256 | $11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $57 | $129 | -$256 | $11 |
| % Margin | 2.4% | 5.3% | -12% | 0.4% |
| EPS | 0.007 | 0.008 | -0.032 | 0.001 |
| % Growth | -15.5% | 126.3% | -2,385.7% | – |
| EPS Diluted | 0.007 | 0.008 | -0.032 | 0.001 |
| Weighted Avg Shares Out | 8,004 | 8,004 | 8,004 | 8,004 |
| Weighted Avg Shares Out Dil | 8,167 | 8,004 | 8,004 | 8,004 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $38 | $41 | $39 |
| Depreciation & Amortization | $56 | $54 | $55 | $54 |
| EBITDA | $114 | $221 | -$160 | $104 |
| % Margin | 4.8% | 9% | -7.5% | 4.3% |